Across TCGA pan-cancer cohorts, LINC01784 RNA is linked to patient survival in 4 of 34 cancer types, making it the most broadly survival-associated LINC01784 data layer.
The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher LINC01784 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated LINC01784 expression acts as an unfavorable survival marker.
UCEC, KIRP, and TGCT are the cancer types where LINC01784 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.